You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

18-450

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Rheumatoid Arthritis Trial in United States (ATI-450 50mg oral tablet BID, Placebo oral tablet, Methotrexate)

Recruiting
  • Rheumatoid Arthritis
  • ATI-450 50mg oral tablet BID
  • +3 more
  • El Cajon, California
  • +24 more
Jan 27, 2023

Chronic Hepatitis C Virus (HCV) Infection Genotype 1 Trial in United States (ABT-450/r/ABT-267, ABT-333, Ribavirin (RBV))

Completed
Has Results
  • Chronic Hepatitis C Virus (HCV) Infection Genotype 1
  • Phoenix, Arizona
  • +47 more
Jun 27, 2022

Cholera Trial in India (Hillchol vaccine, Shanchol Vaccine)

Active, not recruiting
  • Cholera
  • Hillchol vaccine
  • Shanchol Vaccine
  • Visakhapatnam, Andhra Pradesh, India
  • +10 more
Aug 17, 2022

COPD (COPD) Trial in Worldwide (Tozorakimab, Placebo)

Not yet recruiting
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Tozorakimab
  • Placebo
  • Lincoln, California
  • +113 more
Feb 15, 2023

Lymphedema Trial in Australia, United States (ubenimex, )

Completed
Has Results
  • Lymphedema
  • Stanford, California
  • +3 more
Dec 22, 2022

Polymyositis, Dermatomyositis, Autoimmune Necrotizing Myopathy Trial in Worldwide (Abatacept subcutaneous, Placebo)

Terminated
Has Results
  • Polymyositis
  • +4 more
  • Abatacept subcutaneous
  • Placebo
  • Phoenix, Arizona
  • +75 more
Aug 4, 2022

Nasal Polyps Trial in Worldwide (Fevipiprant 150 mg, Fevipiprant 450 mg, Placebo)

Completed
Has Results
  • Nasal Polyps
  • Fevipiprant 150 mg
  • +2 more
  • Irvine, California
  • +24 more
Oct 7, 2021

Coronavirus Trial in Wuhu (Omicron BA.4/5-Delta strain recombinant novel coronavirus protein vaccine (CHO cells), Recombinant

Active, not recruiting
  • Coronavirus
  • Omicron BA.4/5-Delta strain recombinant novel coronavirus protein vaccine (CHO cells)
  • Recombinant novel coronavirus protein vaccine (CHO cells)
  • Wuhu, Anhui, China
    Wannan Medical College Yijishan Hospital
May 6, 2023

Chronic Hepatitis C Infection, Compensated Cirrhosis Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin (RBV))

Completed
Has Results
  • Chronic Hepatitis C Infection
  • Compensated Cirrhosis
  • ABT-450/r/ABT-267, ABT-333
  • Ribavirin (RBV)
  • (no location specified)
Jul 8, 2021

T2DM (Type 2 Diabetes) Trial in Coral Gables (ORMD-0801, Placebo)

Recruiting
  • T2DM (Type 2 Diabetes Mellitus)
  • Coral Gables, Florida
    Research Institute of South Florida, Inc. (PHARMASEEK)
Apr 11, 2022

NSCLC Stage IIIB, ALK Gene Mutation Trial in Mexico City (Alectinib Oral Product)

Recruiting
  • Non-small Cell Lung Cancer Stage IIIB
  • ALK Gene Mutation
  • Alectinib Oral Product
  • Mexico City, Mexico
    Thoracic Oncology Unit and Personalized Medicine Laboratory, Ins
Jan 26, 2023

Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin, Placebo for ABT-450/r/ABT-267)

Completed
Has Results
  • Chronic Hepatitis C Infection
  • ABT-450/r/ABT-267, ABT-333
  • +4 more
  • (no location specified)
Jul 29, 2021

Malaria, Malaria, Vivax, Plasmodium Vivax Malaria Trial in Mae Sot (Dihydroartemisinin-piperaquine plus tafenoquine (450 mg

Not yet recruiting
  • Malaria
  • +2 more
  • Dihydroartemisinin-piperaquine plus tafenoquine (450 mg adult dose)
  • Chloroquine plus Tafenoquine (450 mg adult dose)
  • Mae Sot, Tak, Thailand
    Shoklo Malaria Research Unit (SMRU)
Mar 15, 2023

Food Preferences, Food Selection, Eating, Healthy Trial (Healthy Eating Curriculum, Improving the Classroom Food and Mealtime

Not yet recruiting
  • Food Preferences
  • +3 more
  • Healthy Eating Curriculum
  • +3 more
  • (no location specified)
Jul 28, 2023

Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin, Placebo for ABT-450/r/ABT-267)

Completed
Has Results
  • Chronic Hepatitis C Infection
  • ABT-450/r/ABT-267, ABT-333
  • +4 more
  • (no location specified)
Jul 8, 2021

COVID-19 Trial in Wuhan (Prototype and Omicron BA.4/5 Bivalent Recombinant COVID-19 Vaccine(Adenovirus Type 5 Vector) For

Recruiting
  • COVID-19
  • Prototype and Omicron BA.4/5 Bivalent Recombinant COVID-19 Vaccine(Adenovirus Type 5 Vector) For Inhalation
  • +2 more
  • Wuhan, Hubei, China
    Zhongnan Hospital of Wuhan University
Jun 1, 2023

NSCLC Trial in China, Taiwan (Encorafenib, Binimetinib)

Recruiting
  • Non-Small Cell Lung Cancer
  • Beijing, China
  • +35 more
Jun 29, 2022

Weight Gain, Weight Loss Trial in San Antonio (Gestational weight gain intervention, Postpartum weight loss intervention)

Completed
Has Results
  • Weight Gain
  • Weight Loss
  • Gestational weight gain intervention
  • Postpartum weight loss intervention
  • San Antonio, Texas
  • +1 more
Dec 2, 2022

Asthma Trial in Worldwide (Placebo once daily, QAW039 150 mg once daily, QAW039 450 mg once daily)

Terminated
Has Results
  • Asthma
  • Placebo once daily
  • +2 more
  • Newport Beach, California
  • +120 more
Oct 7, 2021

Blood Vessel Study

Completed
  • Cardiovascular Disease
    • Research Triangle Park, North Carolina
      NIEHS Clinical Research Unit (CRU)
    Jan 25, 2023

    Health Adult Subjects Trial (Omaveloxolone, Moxifloxacin)

    Not yet recruiting
    • Health Adult Subjects
    • (no location specified)
    Jun 28, 2023

    Uterine Sarcoma Trial (Everolimus)

    Available
    • Uterine Sarcoma
    • (no location specified)
    Aug 25, 2022

    Atopic Dermatitis Trial (Caffeine, Metoprolol, Midazolam)

    Not yet recruiting
    • Atopic Dermatitis
    • Caffeine
    • +6 more
    • (no location specified)
    May 26, 2023

    Hepatitis C Virus Trial (ABT-450/r/ABT-267, Ribavirin)

    Completed
    Has Results
    • Hepatitis C Virus
    • (no location specified)
    Jul 28, 2021

    Drug Interactions Trial in Austin (CYP450 Cocktail and Transporter Substrates with Pacritinib, Part 2 -Group A Bosentan 125 mg

    Recruiting
    • Drug Interactions
    • CYP450 Cocktail and Transporter Substrates with Pacritinib
    • +2 more
    • Austin, Texas
      PPD - Austin Research Unit
    Jan 13, 2023